telmisartan has been researched along with 4-hydroxy-2-nonenal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, K; Deguchi, K; Fukui, Y; Hishikawa, N; Kurata, T; Lukic, V; Sato, K; Yamashita, T | 1 |
1 other study(ies) available for telmisartan and 4-hydroxy-2-nonenal
Article | Year |
---|---|
Telmisartan reduces progressive oxidative stress and phosphorylated α-synuclein accumulation in stroke-resistant spontaneously hypertensive rats after transient middle cerebral artery occlusion.
Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Brain; Glycation End Products, Advanced; Hypertension; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Oxidative Stress; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Wistar; Synucleins; Telmisartan | 2014 |